Assembly Bill A8601A

2015-2016 Legislative Session

Limits the initial prescription of a controlled substance for the alleviation of acute pain

download bill text pdf

Sponsored By

Archive: Last Bill Status - In Assembly Committee


  • Introduced
    • In Committee Assembly
    • In Committee Senate
    • On Floor Calendar Assembly
    • On Floor Calendar Senate
    • Passed Assembly
    • Passed Senate
  • Delivered to Governor
  • Signed By Governor

Do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.
Actions

Bill Amendments

co-Sponsors

2015-A8601 - Details

See Senate Version of this Bill:
S6091
Current Committee:
Assembly Rules
Law Section:
Public Health Law
Laws Affected:
Amd §3331, Pub Health L
Versions Introduced in Other Legislative Sessions:
2011-2012: S6745
2013-2014: A10111, S2949

2015-A8601 - Summary

Limits the initial prescription of a controlled substance for the alleviation of acute pain.

2015-A8601 - Bill Text download pdf

                            
                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                  8601

                       2015-2016 Regular Sessions

                          I N  A S S E M B L Y

                            December 2, 2015
                               ___________

Introduced by M. of A. McDONALD, CUSICK -- read once and referred to the
  Committee on Health

AN  ACT  to  amend  the  public  health law, in relation to limiting the
  initial prescription of a controlled substance for the alleviation  of
  acute  pain  to  between  a  three to ten day supply; and to amend the
  insurance law, in relation to coverage of such prescriptions

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section  1. Subdivision 5 of section 3331 of the public health law, as
amended by chapter 965 of the laws  of  1974,  is  amended  to  read  as
follows:
  5. (A) No more than a thirty day supply or, pursuant to regulations of
the  commissioner  enumerating  conditions  warranting specified greater
supplies, no more than a three month supply of a schedule II, III or  IV
substance, as determined by the directed dosage and frequency of dosage,
may be dispensed by an authorized practitioner at one time.
  (B)  NOTWITHSTANDING  THE PROVISIONS OF PARAGRAPH (A) OF THIS SUBDIVI-
SION, AN AUTHORIZED PRACTITIONER, WITHIN THE SCOPE OF HIS OR HER PROFES-
SIONAL OPINION OR DISCRETION, MAY DISPENSE OR  PRESCRIBE  NO  MORE  THAN
BETWEEN  A THREE AND TEN DAY SUPPLY OF ANY SCHEDULE II OR III CONTROLLED
SUBSTANCE TO AN ULTIMATE USER UPON THE INITIAL CONSULTATION OR TREATMENT
OF SUCH USER FOR ACUTE PAIN.  THEREAFTER, THE DISPENSING AND PRESCRIBING
OF THE CONTROLLED SUBSTANCE SHALL BE SUBJECT TO THE PROVISIONS OF  PARA-
GRAPH (A) OF THIS SUBDIVISION.
  (C)  FOR  THE  PURPOSES  OF THIS SUBDIVISION, "ACUTE PAIN" MEANS PAIN,
WHETHER ACCIDENTAL OR INTENTIONAL, THAT LASTS ONLY  A  SHORT  OR  FINITE
PERIOD OF TIME. SUCH TERM SHALL NOT INCLUDE CHRONIC PAIN, CANCER PAIN OR
PALLIATIVE CARE PRACTICES.
  S 2. Subsection (i) of section 3216 of the insurance law is amended by
adding a new paragraph 32 to read as follows:

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD03975-02-5

              

co-Sponsors

multi-Sponsors

2015-A8601A (ACTIVE) - Details

See Senate Version of this Bill:
S6091
Current Committee:
Assembly Rules
Law Section:
Public Health Law
Laws Affected:
Amd §3331, Pub Health L
Versions Introduced in Other Legislative Sessions:
2011-2012: S6745
2013-2014: A10111, S2949

2015-A8601A (ACTIVE) - Summary

Limits the initial prescription of a controlled substance for the alleviation of acute pain.

2015-A8601A (ACTIVE) - Bill Text download pdf

                            
                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                 8601--A

                       2015-2016 Regular Sessions

                          I N  A S S E M B L Y

                            December 2, 2015
                               ___________

Introduced by M. of A. McDONALD, CUSICK, MAYER, RYAN, STECK -- read once
  and  referred to the Committee on Health -- recommitted to the Commit-
  tee on Health in accordance with Assembly Rule 3, sec. 2 --  committee
  discharged, bill amended, ordered reprinted as amended and recommitted
  to said committee

AN  ACT  to  amend  the  public  health law, in relation to limiting the
  initial prescription of a controlled substance for the alleviation  of
  acute pain

  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. Subdivision 5 of section 3331 of the public health law,  as
amended  by  chapter  965  of  the  laws  of 1974, is amended to read as
follows:
  5. (A) No more than a thirty day supply or, pursuant to regulations of
the commissioner enumerating  conditions  warranting  specified  greater
supplies,  no more than a three month supply of a schedule II, III or IV
substance, as determined by the directed dosage and frequency of dosage,
may be dispensed by an authorized practitioner at one time.
  (B) A PRACTITIONER MAY NOT PRESCRIBE MORE THAN A FIVE  DAY  SUPPLY  OF
ANY  SCHEDULE  II  OR  III  CONTROLLED  SUBSTANCE FOR A PATIENT UPON THE
INITIAL CONSULTATION OR TREATMENT OF THE PATIENT FOR ACUTE PAIN.   AFTER
ISSUING THE INITIAL PRESCRIPTION AND EVALUATING THE PATIENT'S CONDITION,
THE  PRACTITIONER  MAY  ISSUE  ANY  APPROPRIATE  RENEWAL,  REFILL OR NEW
PRESCRIPTION FOR THE CONTROLLED SUBSTANCE OR OTHER DRUG FOR THE PATIENT.
  (C) FOR THE PURPOSES OF THIS  SUBDIVISION,  "ACUTE  PAIN"  SHALL  MEAN
PAIN,  WHETHER RESULTING FROM DISEASE, ACCIDENTAL OR INTENTIONAL TRAUMA,
OR OTHER CAUSE, THAT IS REASONABLY EXPECTED TO  LAST  ONLY  A  SHORT  OR
FINITE  PERIOD  OF  TIME.  SUCH TERM SHALL NOT INCLUDE CHRONIC PAIN,  OR
PAIN BEING TREATED AS PART OF CANCER CARE, HOSPICE OR OTHER  END-OF-LIFE
CARE.
  S 2. This act shall take effect on the one hundred eightieth day after
it shall have become a law.

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
              

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.